Skip to content

ROSA Oligomineral Water for Oral Hydration in 6-Month-Old Healthy Infants

Short-term Safety of ROSA Oligomineral Water in Healthy Serbian Infants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04012372
Acronym
ROSAH
Enrollment
65
Registered
2019-07-09
Start date
2019-07-20
Completion date
2019-10-07
Last updated
2019-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydration

Keywords

Infants, Water, Safety

Brief summary

The present study evaluates the safety of ROSA oligomineral water in 6-to-12-month old healthy children.

Detailed description

Our study is designed as an open-label case-control interventional study that evaluates the safety of 28-day hydration with ROSA water in healthy infants aged 6-12 months. The participants are apparently healthy children breastfed or formula fed; minimal sample size (n = 52) was calculated according to 0.8 power to detect a significant difference in the prevalence of diarrhea (G\*Power 3.1). Final group of participants will consist of sixty-five healthy male and female infants (we presume that 20% of participants will drop-out throughout the study). The stopping rules for participants include a refuse to participate in this research at any time and significant change of health status. All participants will be allocated in an open-label manner to two randomly assigned ad libitum hydration regimens: first group will receive ROSA water for daily hydration, and second (control) group will receive other water of personal choice (including tap water). All testing including parental diary of infant general status (e.g. daily amount of water consumed, number of stools per day, nutritional habits) and clinician-reported outcomes (e.g. body weight, clinical evaluation of hydration will be conducted at pre-administration (baseline) and at follow-up (after 28 days of administration). The study is entirely voluntary and the participants are free to stop participating at any time.

Interventions

OTHERROSA Water

Ad libitum hydration with ROSA oligomineral water

Ad libitum hydration with other waters

Sponsors

Dom Zdravlja Nis
CollaboratorUNKNOWN
University of Novi Sad, Faculty of Sport and Physical Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

All participants will be allocated in an open-label manner to two randomly assigned ad libitum hydration regimens: first group will receive ROSA water for daily hydration, and second (control) group will receive other water of personal choice (including tap water)

Eligibility

Sex/Gender
ALL
Age
6 Months to 12 Months
Healthy volunteers
Yes

Inclusion criteria

* Age 6 to 12 months * Healthy children * Doubled weight at 6 months * Tripled weight at 12 months * Feed with breast milk of milk formula

Exclusion criteria

* Any acute or chronic disease * Unwillingness to return for follow-up analysis

Design outcomes

Primary

MeasureTime frameDescription
Daily amount of water consumedBaseline vs. 28-daysMonitor change in daily amount of water consumed

Secondary

MeasureTime frameDescription
Number of stools per dayBaseline vs. 28-daysMonitor change in number of stools per day
Body weightBaseline vs. 28-daysMonitor change in body weight
Hydration statusBaseline vs. 28-daysMonitor clinican-reported change in hydration status

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026